The Vaxcel® Port with PASV® Valve has shown demonstrated results in clinical and economic outcomes.* The PASV® Valve is a proximally located valve in the port body, designed to automatically close after infusion, disconnection or aspiration, and remain closed during normal pressure fluctuations.
An advantage of the PASV® Valve Technology is a proximally located, direction-specific valve that is designed to resist backflow and maintain patency between uses.
Ports with PASV® Valve Technology have shown significant reductions in inadequate blood draws and occlusion in clinical studies.1
Savings in Vaxcel® Port with PASV® Valve Technology maintenance and access time may offset acquisition costs, resulting in significant net savings compared to non-valved ports.
PASV® Valve Technology is designed to automatically close after infusion, upon disconnection or after sampling, and automatically remain closed during normal pressure fluctuations.
A large septum enhances ease of access. Vaxcel® Port with PASV® Valve Technology provides a larger target area than the leading competitor. Vaxcel® Mini Port with PASV® Valve Technology also provides a larger target area than the leading competitor.*
The Vaxcel® Mini Port with PASV® Valve Technology provides a lower profile than the leading competitive standard profile port.*
The twist-on locking collar provides an easy-to-grip design, intended to ease collar advancement to facilitate attachment. The connection is designed to promote secure attachment to the barbed port stem.
The trimmable, marked, thin-walled catheters consist of biocompatible, durable silicone or polyurethane materials.
1. Low profile, compact design
2. Significantly larger septum
3. PASV® Valve
4. Twist-on locking collar
5. Marked radiopaque catheter
1. Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA. A Prospective Randomized Trial Demonstrating Valved Implantable Ports Have Fewer Complications and Overall Cost than Non-Valved Implantable Ports. AM J Surg 2004;188:722-727.
*Data on file at Navilyst Medical.